Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis

In multiple sclerosis (MS), treatment with the monoclonal antibody natalizumab effectively reduces the formation of acute lesions in the central nervous system (CNS). Natalizumab binds the integrin very late antigen (VLA)-4, expressed on the surface of immune cells, and inhibits VLA-4 dependent tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Börnsen, Lars, Christensen, Jeppe Romme, Ratzer, Rikke, Oturai, Annette Bang, Sørensen, Per Soelberg, Søndergaard, Helle Bach, Sellebjerg, Finn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511477/
https://www.ncbi.nlm.nih.gov/pubmed/23226199
http://dx.doi.org/10.1371/journal.pone.0047578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511477/
https://www.ncbi.nlm.nih.gov/pubmed/23226199
http://dx.doi.org/10.1371/journal.pone.0047578

Ejemplares similares